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Background: Bacterial vaginosis (BV) is a common pathology of women in reproductive age that can lead to
serious health complications, and is associated with shifts in the normal microflora from predominance of
Lactobacillus spp. to a proliferation of other anaerobes such as G. vaginalis and A vaginae, which can be detected by
PCR. The optimal PCR pathogen detection assay relies mainly on the specificity and sensitivity of the primers used.
Findings: Here we demonstrate that in silico analytical testing of primer specificity is not a synonym to in vitro
analytical specificity by testing a range of published and newly designed primers with both techniques for the
detection of BV-associated microorganisms.
Conclusions: By testing primer in vitro specificity with a sufficient range of bacterial strains, we were able to design
primers with higher specificity and sensitivity. Also by comparing the results obtained for the newly designed
primers with other previously published primers, we confirmed that in silico analysis is not sufficient to predict
in vitro specificity. As such care must be taken when choosing the primers for a detection assay.
Keywords: Primer specificity, Primer sensitivity, In silico primer testing, In vitro primer testing, G. vaginalis, A. vaginae,
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Bacterial vaginosis (BV) is one of the most common vaginal
disorders of women in reproductive age and is reported to
be linked to increased risks of pre-term labor, HIV infec-
tion, postoperative infection and inflammatory pelvic
disease [1]. It has been recognized that this pathology is
caused by a shift in the microbial ecosystem colonizing the
vagina of healthy women; from a Lactobacillus spp. domi-
nated microbial population to the proliferation of other
anaerobic microorganisms such as Gardnerella vaginalis,
Atopobium vaginae, Mobiluncus spp. among others [2-4].
The etiology of BV remains unknown but a recent study
reported that microbial biofilms, complex tridimensional
structures that are known to be highly resistant to anti-
microbial chemotherapy [5], may play a fundamental role in
BV [6]. It has been described that G. vaginalis may account
for 60 to 90% of the BV biofilm mass, while A. vaginae may* Correspondence: nunocerca@ceb.uminho.pt
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distribution, and reproduction in any mediumaccount for 1 to 40% and Lactobacillus spp. for 1 to 5% [7].
While trying to confirm these findings, in biofilms from
vaginal samples of Portuguese women, using a quantitative
PCR approach, we came across some difficulties related
with primer specificity, despite the increase in the number
of published papers regarding the use of molecular tools,
such as PCR, for the detection of BV-associated micro-
organism [8-11]. In order to assess the usefulness of the
primers for the detection of our target microorganisms used
we decided to test the analytical specificity (% of non-target
organisms detected) and sensitivity (% of target organisms
detected) of the primers used. Being a quick and inexpen-
sive method, in silico analysis of primer specificity and
sensitibity has been widely used. However this technique
poses some limitations, already described for other applica-
tions, namelly significant differences between the in silico
prediction for primer specificity/sensitivity and the actual
in vitro results [8,9].
To our knowledge the analytical comparison of primer in
silico and in vitro specificity/sensitivity for primers designed
for the detection of BV-associated microorganisms has nottral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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techniques for the study of BV such information becomes
relevant.
We began by selecting primers previously described in
the literature specific for Lactobacillus spp. [12,13], G.
vaginalis [8,14] and A. vaginae [11,15]. The reported
primers specificity was mainly determined by in silico
analysis using sequence alignment such as BLAST
[16]. Whenever in vitro specificity was reported, often
published details of such specificity determinations
were scarce. When confirming primer specificity, using a
few collection strains, and the same conditions reported
in the literature, we found that some in silico primer spe-
cificity did not correspond to the in vitro specificity (data
not shown). To address this, we selected the best primers
that we could find in the literature and repeated the in
silico specificity analysis using ProbeMatch [17]. We also
designed new primers (using VectorNTI, version 11.0
and sequences available in the GeneBank databases)
(Table 1).
During in silico analysis of the selected primers, we
found two main problems: (i) the selected published pri-
mers for G. vaginalis were designed for the 16S rRNA-
encoding DNA and 23S rRNA-encoding DNA intergenic
region [8,14] and there are no available databases which
include this region that could be used for the in silicoTable 1 In silico analysis of primer specificity of the primers u
Target Probe Sequence (50→ 30) No. of
strains de
G. vaginalis Gard154-454 Fw CTCTTGGAAACGGGTGGTAA 36 (fro
Rv TTGCTCCCAATCAAAAGCGGT 38 (fro
GV1 + 3 Fw TTACTGGTGTATCACTGTAAGG
Rv CCGTCACAGGCTGAACAGT
Gv1 + 2 Fw TCCTGTCTACCAAGGCATCC
Rv CGTGTGATAACCGTCAGGTG
A. vaginae Atop109-329 Fw GAGTAACACGTGGGCAACCT 457 (fro
Rv CCGTGTCTCAGTCCCAATCT 449 (fro
AtovagRT3 Fw GGTGAAGCAGTGGAAACACT 134 (fro
Rv ATTCGCTTCTGCTCGCGCA 109 (fro
Atop167-587 Fw GCGAATATGGGAAAGCTCCG 117 (fro
Rv TCATGGCCCAGAAGACCGCC 115 (fro
Lactobacillus
spp.
AM Lacto Fw TGATGCATAGCCGAGTTGAG 7353 (from
Rv AGCCGAAACCCTTCTTCACT 5858 (from
New Lacto Fw TGGAAACAGRTGCTAATACCG 11680 (fro
Rv GTCCATTGTGGAAGATTCCC 10113 (fro
S21 + A19 Fw TGCCTAATACATGCAAGTCGA 9754 (from
Rv GTTTGGGCCGTGTCTCAGT 10157 (fro
Empty boxes correspond to the primers that could not be analysed because there a
and 23S rRNA genes for the in silico analysis.
aCalculated using ProbeMatch (last accession, May 2012) with the following data se
bFormula: Specificity = (nts/Tnts)*100 (nts: number of non-target strains undetec
Sensitivity = (ts/Tts)*100 (ts: number of target strains detected, Tts: totanalysis; (ii) some of the primers for A. vaginae and
Lactobacillus spp. showed low sensitivity in silico. In
order to confirm our in silico analysis, in vitro testing of
primer specificity was performed, initially with 3 strains
of each target (G.vaginalis, A. vaginae and Lactobacillus
spp., details in Additional file 1: Table S1), using
DyNAnzyme PCR Master Mix 2x (Finnenzymes,
Thermo Scientific, Finland). The initial amplification
conditions comprised 40 cycles with the following tem-
peratures each cycle: 94°C for 30 seconds, 60°C for
30 seconds, and 72°C for 1 minute. Amplified products
were analysed in a 1% agarose gel and stained with Mid-
ori Green nucleic acid dye (Nippon Genetics Europe
GmbH, Germany). Results of the PCR at 60°C showed
low sensitivity and specificity for Lactobacillus spp. pri-
mers, and as such we decided to optimize this detection
with the aim of obtaining a greater specificity. The
annealing temperature was then adjusted to 62°C, and
the number of strains increased to a total of 12 target
strains (per group) and up to 34 non-target strains
(including Pseudomonas aeruginosa, Staphylococcus
epidermidis, Streptococcus agalactiae, Enterococcus
faecalis, Escherichia coli and Staphylococcus cohnii)
(Table 2). We used different annealing temperatures, in
order to observe the effect that this variation would
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G. vaginalis Gard154-454 60 3 (from 3) 100.0 0 (from 6) 100.0 This study
62 12 (from 12) 100.0 0 (from 34) 100.0
GV1 + 3 60 3(from 3) 100.0 0 (from 6) 100.0 [15]
62 10 (from 12) 83.3 0 (from 34) 100.0
Gv1 + 2 60 3 (from 3) 100.0 0 (from 6) 100.0 [13]
62 11 (from 12) 91.7 0 (from 34) 100.0
A. vaginae Atop109-329 60 3 (from 3) 100.0 5 (from 6) 16.7 This study
62 12 (from 12) 100.0 15 (from 24) 37.5
66 12 (from 12) 100.0 3 (from 34) 91.2
AtovagRT3 60 12 (from 12) 100.0 1 (from 24) 95.8 [11]
62 12 (from 12) 100.0 2 (from 34) 94.1
Atop167-587 60 2 (from 3) 66.7 0 (from 6) 100.0 [10]
62 11 (from 12) 91.6 4 (from 34) 88.3
Lactobacillus spp. AM Lacto 60 2 (from 12) 16.7 1 (from 24) 95.8 This study
58 2 (from 12) 16.7 3 (from 34) 91.2
New Lacto 60 5 (from 12) 41.7 18 (from 34) 47,1 [16]
62 1 (from 12) 8.3 8 (from 24) 66.7
S21 + A19 60 5 (from 12) 41.7 24 (from 24) 0 [17]
62 6 (from 12) 50.0 34 (from 34) 0
aCalculated using ProbeMatch (last accession, May 2012) with the following data set options: Strain – Both; Source – Both; Size – > 1200 bp; Quality – Both.
bFormula: Specificity = (nts/Tnts)*100 (nts: number of non-target strains undetected, Tnts: total number of non-target strains tested).
Sensitivity = (ts/Tts)*100 (ts: number of target strains detected, Tts: total number of target strains tested).
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mers in combination (for multiplex PCR assays for
example) for quick and effective PCR detection assay.
When comparing in silico predictions against in vitro
results, we found considerable differences in specificity
and sensitivity values. Despite the fact that theoretical
melting temperature of the A. vaginae primers designed
in this study was 60°C, at this temperature primer
specificity was very low. Only with higher annealing
temperature (66°C), we could achieve reasonable specifi-
city (91.2%) and sensitivity (100%) values. The primers
for Lactobacillus spp. were the ones with the lowest spe-
cificity. Of note, some of the primers previously reported
as specific were found to be non-specific (0%) despite an
in silico prediction of 81% of specificity. A lower specifi-
city was expected since these primers were designed for
the identification of a genus, which results in a higher
inherent genetic variability than primers for the identifi-
cation a species. However, the accentuated decrease
between in silico and in vitro primer specificity was not
anticipated. The primers described by Pepin et al. (10)
revealed the highest specificity for A. vaginae (Table 2),
probably due to the previous in vitro specificity analysis
against at least 20 isolates that was performed by the
authors [10]. Although A. vaginae primers demonstrated
an overall lower specificity, they proved to be highlysensitive, being able to detect all the targets used
(Table 2). It is worth to note that the primer designed
for this study for the detection of G. vaginalis proved to
have a higher sensitivity than that of published primers,
and that contrary to the results obtained for the other
target microorganisms, the in silico prediction of sensi-
tivity and specificity was similar to the in vitro results
obtained.
It is interesting to note that in silico analysis for
primers specificity was not a good predictor of in vitro
primer specificity, something already reported by other
researchers [8,9], in silico predictions do not take into
account the chemical reactions/limitations that can
occur in the PCR tube and as such cannot truly approxi-
mate experimental events. In most articles describing
the detection of BV-associated microorganisms the primer
specificity testing is described as being performed in silico
[10-15]. This work confirms the importance of proper
in vitro analysis of primer specificity, as the in silico ana-
lysis can sometimes underestimate the possible cross reac-
tion with non-sense strains or species which are not yet
sequenced, as is the case of most of the strains present in
vaginal environment. Furthermore, the new G. vaginalis
and A. vaginae primers reported here have high in vitro
specificity, demonstrating its potential for use in clinical
microbiology.
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Additional file 1: Table S1. Description of name and origin of strains
used in this study for the in vitro testing of primer specificity and
sensitivity.
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